INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 28
RESEARCH DOSSIER / NOT AN ENDORSEMENT

AM Rx

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Affordable virtual care with or without insurance; same-day appointments; weight loss program pairing insurance-covered brand GLP-1s with compounded options; '$96 off' promo.

Audienceread

READ: mainstream insured adults wanting convenience; broad (birth control, ED, mental health), testimonials from NY/CA/FL users.

Pricing & termspartial

With insurance: Ozempic/Wegovy/Zepbound/Mounjaro 'as low as $25/mo'; semaglutide 'as low as $106/mo' (quarterly); compounded self-pay price not itemized.

Clinical relationshipsverified

Bruno Health, P.A. and affiliated medical groups (telehealth consent). Operator FitRX, LLC dba AM Rx.

Pharmacy & fulfillmentpartial

Unnamed 'Pharmacy partners'; patient may choose own pharmacy. FDA warning letter (June 8, 2026) says labels showing 'AM Rx' imply it compounds when it does not.

Advertising snapshotsnapshot

Meta US active exact-phrase keyword: ~10 results. Google US last-30-days domain search: 2 ads. Sample last shown Oct 10, 2026.

Founding yearnot_found

Not found.

    Foundersverified

    Kyle Robertson, Founder & CEO (as addressee of FDA letter).

    Location & entity contextverified

    30 Irving Pl, Floor 7, New York, NY 10003 (privacy policy/FDA letter); site footer shows mailing 8 The Green, Dover DE.

    Search visibility samplesnapshot

    Free domain-restricted search returned 15 result(s) in a bounded sample, not an indexed-page count; top pages listed in sources. No rank/traffic data (paid analytics excluded).

    THE MODERN DOSING WEEKLY

    The peptide news
    that changes your week.

    Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.